Background
Non-alcoholic fatty liver disease (NAFLD) and its progressive stage, non-alcoholic steatohepatitis (NASH), are among the leading causes of chronic liver disease with limited treatment options. Dysregulation of PI3K/AKT, EGFR, and TNF-α signaling pathways plays a central role in their progression. Traditional medicinal plants, such as Achillea millefolium, are abundant in phytochemicals with potential therapeutic effects.
Objectives
This study aimed to identify and evaluate bioactive compounds from A. millefolium with potential activity against NAFLD/NASH using network pharmacology, bioinformatics, molecular docking, and ADME profiling, while exploring their multi-target synergy through network pharmacology.
Methods
Phytochemicals were collected from literature and curated databases. Potential targets were predicted via SwissTarget, PharmMapper, and SuperPred, while NAFLD/NASH-related genes were obtained from GeneCards. Common targets were identified through Venn analysis and integrated into protein-protein interaction and pathway networks in Cytoscape. Functional enrichment was conducted using DAVID. Key hub-targets (AKT1, PIK3CA, EGFR, TNF-α) were validated by molecular docking and MM-GBSA binding energy calculations. Pharmacokinetic profiles were assessed using ADMETLab 3.0, and recent nano-formulation studies were reviewed to support translational potential. Transcriptomic data further validated hub-target involvement.
Results
Network analysis highlighted multiple hub-targets and pathways. Luteolin glycosides, rutin, and apigenin showed strong binding with PI3K/AKT1 and EGFR, while vicenin-2 demonstrated affinity for TNF-α. However, glycosylated flavonoids displayed low predicted absorption and high polarity, suggesting poor bioavailability. Nanoformulations such as polymeric nanoparticles and lipid nanocapsules may improve delivery.
Conclusion
This integrative study underscores the therapeutic promise of A. millefolium, particularly luteolin glycosides, apigenin, rutin, and vicenin-2, in modulating PI3K/AKT-driven NAFLD/NASH pathology.
扫码关注我们
求助内容:
应助结果提醒方式:
